Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Dec, 9 2025
Nov, 14 2025
Mar, 22 2024
Mar, 4 2026
Oct, 3 2025